Month: April 2020

NEW YORK, April 16, 2020 (GLOBE NEWSWIRE) — 8i Enterprises Acquisition Corp. (NASDAQ: JFKKU, JFK, JFKKW, JFKKR) (“JFK” or the “Company”), a special purpose acquisition company, today announced that Diginex, a digital asset financial services and advisory company with which JFK entered into a definitive share exchange agreement dated July 9, 2019, announced today that Digivault, a secure digital asset custody provider and a Diginex group company, launched Helios, a warm custody solution.The Helios design meets the stringent standards demanded by the world’s most secure systems. Helios delivers logical protection against key duplication and/or theft, hardware protection of networks and operates from multiple military-grade secure locations run by a recognised third-party provider.Helios seamlessly integrates with Digivault’s cold...

Hoivatilat PlcStock exchange release16 April 2020 at 2:15 pm EETHoivatilat Plc applies for delisting of its shares from Nasdaq HelsinkiThe board of directors of Hoivatilat Plc (“Hoivatilat”) has decided to apply for the termination of public trading in Hoivatilat’s shares and for delisting of Hoivatilat’s shares from the official list of Nasdaq Helsinki Ltd (“Nasdaq Helsinki”).Aureit Holding Oy (“Aureit Holding”) owns more than nine-tenths (9/10) of all shares and voting rights in Hoivatilat and has therefore initiated arbitration proceedings in accordance with Chapter 18 of the Finnish Companies Act (the “Companies Act”) in order to redeem all the remaining shares in Hoivatilat held by the minority shareholders. Aureit Holding has requested the arbitral tribunal appointed for...

Hoivatilat OyjPörssitiedote16.4.2020 klo 14:15 EETHoivatilat Oyj hakee osakkeidensa poistamista Nasdaq Helsingin pörssilistaltaHoivatilat Oyj:n (“Hoivatilat”) hallitus on päättänyt hakea julkisen kaupankäynnin lopettamista Hoivatilojen osakkeilla ja Hoivatilojen osakkeiden poistamista Nasdaq Helsinki Oy:n (“Nasdaq Helsinki”) pörssilistalta.Aureit Holding Oy (“Aureit Holding”) omistaa yli yhdeksän kymmenesosaa (9/10) kaikista Hoivatilojen osakkeista ja äänioikeuksista ja on siten käynnistänyt osakeyhtiölain (“OYL”) 18 luvun mukaisen välimiesmenettelyn lunastaakseen kaikki jäljellä olevat Hoivatilojen vähemmistöosakkeenomistajien hallussa olevat osakkeet. Aureit Holding on pyytänyt, että lunastusmenettelyä varten nimitetty välimiesoikeus vahvistaa Aureit Holdingin lunastusoikeuden ja että...

LONDON, April 16, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that all resolutions proposed at the Annual General Meeting held today were duly approved by shareholders by way of a poll. The results of the poll are available on the Investors section of the Company’s website, www.veronapharma.com.About Verona PharmaVerona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. If successfully developed and approved, Verona Pharma’s product candidate, ensifentrine, has the potential to be the first therapy for the...

Flöggunartilkynning er í viðhengi.Viðhengi20.04.16 Flöggun – Gildi-lífeyrissjóður

Bestyrelsen i Kapitalforeningen Accunia Invest har godkendt nedennævnte udbytter for første kvartal af 2020.De optjente udbytter er vist i nedenstående tabel. Tallene er opgjort i kr. pr. investeringsbevis.Automatisk geninvestering – For automatisk geninvestering skal investor kontakte sin egen depotbank. Geninvesteringskurserne fastsættes og gennemføres til indre værdier per den 27. april 2019 fratrukket udbytte.Tidsplan24. april 2020 – Sidste dag for handel med beviser inkl. udbytte27. april 2019 – Udbyttet fragår, og investeringsbeviserne handles uden udbytte29. april 2019 – Udbyttet er til disposition på investors kontoKontaktperson(er):Direktør Caspar Møller, tlf. +45 3332 7070.Yderligere oplysninger om Kapitalforeningen Accunia Invest findes på www.accunia.com.

ANN ARBOR, Mich., April 16, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces the Company will an online press conference, today at 4:30 p.m. Eastern Time, to introduce a game changing Spider Silk technological breakthrough.  This conference will open to all press, stakeholders and interested parties, via a live streaming broadcast at www.kblbinvestors.com/live.The webcast will be accessible on most operating systems and browsers and a replay will be available, following the event, within the Investor Relations section of the Company’s web site.To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.About Kraig Biocraft Laboratories, Inc.Kraig Biocraft Laboratories,...

Phase 1b trial with intranasal betahistine for prevention of antipsychotic-induced weight gain progressing towards final read-outPhase 2 trial with intranasal betahistine for treatment of acute vertigo progressing towards interim analysis, but temporarily slowed down by COVID-19 impactNotice of allowance granted for NKCC1 modulators for oral treatment of tinnitusSet-up of subsidiary to bundle tinnitus and hearing loss development projects for potential partnering       Hamilton, Bermuda, April 16, 2020 – Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today provided a business update and announced financial results for the second half and full year ended December 31, 2019.“We made substantial progress with our intranasal betahistine...

MIDLAND, Texas, April 16, 2020 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it has revised its first quarter 2020 conference call time.Diamondback will host a conference call and webcast for investors and analysts to discuss its results for the first quarter of 2020 on Tuesday, May 5, 2020 at 9:00 a.m. CT, one hour later than previously scheduled.  Participants should call (877) 440-7573 (United States/Canada) or (253) 237-1144 (International) and use the confirmation code 1072965.  A telephonic replay will be available from 12:00 p.m. CT on Tuesday, May 5, 2020, through Tuesday, May 12, 2020 at 12:00 p.m. CT.  To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406 (International) and enter confirmation code 1072965.  A live broadcast of the earnings...